Vivos RDGL
OTC RDGL
$0.04 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos (RDGL) EBITDA Margin (2010 - 2026)

Updated

Vivos' EBITDA Margin came in at -1484.78% for Q1 2026.

Analysis

Vivos (RDGL) EBITDA Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Vivos reported EBITDA Margin of -655.21%; for FY2025, it was -4628.14%.

  • The Q1 2026 figure represents the highest quarterly EBITDA Margin since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 20.09%
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 25.90%
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 25.55%
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 20.38%
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 20.05%
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 24.62%
10 Vivos 19.77 Mn 19.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,484.78%
Mar 31, 2017 2,440.87%
Sep 30, 2016 -16,420.23%
Jun 30, 2016 -77,419.73%
Mar 31, 2016 -9,423.29%
Sep 30, 2015 -682.26%
Mar 31, 2015 -1,242.44%
Jun 30, 2014 -5,068.26%
Mar 31, 2014 18.27%
Sep 30, 2013 -402.46%
Mar 31, 2013 -4,042.96%
Dec 31, 2012 -1,992.55%
Sep 30, 2012 -1,560.27%
Jun 30, 2012 -3,214.87%
Mar 31, 2012 -1,242.95%
Dec 31, 2011 -1,243.22%
Sep 30, 2011 -679.34%
Jun 30, 2011 -308.98%
Mar 31, 2011 -369.38%
Dec 31, 2010 -2,180.37%
API Access

Vivos EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RDGL&period=max&api_key=YOUR_API_KEY